MiNK Therapeutics, Inc.
Biotechnology company · New York, United States · Nasdaq: INKT
MiNK Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker INKT. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $306,500 in total, most recently in 2025.
MiNK Therapeutics at a glance
What does MiNK Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $306,500 in total (2025). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Frequently asked questions about MiNK Therapeutics
Where is MiNK Therapeutics headquartered?
MiNK Therapeutics, Inc. is headquartered in New York, United States.
What does MiNK Therapeutics do?
MiNK Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is MiNK Therapeutics a public company?
Yes. MiNK Therapeutics, Inc. trades on Nasdaq under the ticker INKT.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.